Ranjan Preet
Impact in
- Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Cancer therapeutics and mechanisms 6
- RNA Research and Splicing 5
- RNA modifications and cancer 5
- DNA Repair Mechanisms 3
- Extracellular vesicles in disease 3
- Oncology 6
- Co-authors
- Chanakya Nath Kundu (17 shared papers)Purusottam Mohapatra (14 shared papers)Tathagata Choudhuri (7 shared papers)Shakti Ranjan Satapathy (12 shared papers)Dipon Das (12 shared papers)Michael D. Wyatt (7 shared papers)Dan A. Dixon (10 shared papers)Sankar K. Guchhait (5 shared papers)
- Journals
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (3 papers)Cancer Research (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Oncotarget (2 papers)Nanomedicine (1 paper)
- Partner nations
- IndiaUnited StatesSwitzerland
In The Last Decade
Ranjan Preet
29 papers receiving 1.5k citations
Ranjan Preet's Hit Papers
Peers
Comparison fields: 5 of 83
- Toxicology 85
- Cancer Research 215
- Organic Chemistry 404
- Molecular Biology 839
- Oncology 232
Countries citing papers authored by Ranjan Preet
This map shows the geographic impact of Ranjan Preet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ranjan Preet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ranjan Preet more than expected).
Fields of papers citing papers by Ranjan Preet
This network shows the impact of papers produced by Ranjan Preet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ranjan Preet. The network helps show where Ranjan Preet may publish in the future.
Co-authors
The 25 scholars most cited alongside Ranjan Preet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 273 | |
| 2 | 2020 | 159 | |
| 3 | 2013 | 130 | |
| 4 | 2011 | 127 | |
| 5 | 2016 | 98 | |
| 6 | 2012 | 93 | |
| 7 | 2012 | 79 | |
| 8 | 2011 | 58 | |
| 9 | 2012 | 55 | |
| 10 | 2014 | 55 | |
| 11 | 2014 | 51 | |
| 12 | 2017 | 42 | |
| 13 | 2014 | 40 | |
| 14 | 2013 | 37 | |
| 15 | 2013 | 34 | |
| 16 | Gut commensal Bifidobacterium-derived extracellular vesicles modulate the therapeutic effects of anti-PD-1 in lung cancer Hit paper breakdown → | 2025 | 31 |
| 17 | 2022 | 31 | |
| 18 | 2020 | 29 | |
| 19 | 2016 | 25 | |
| 20 | 2016 | 22 |
About Ranjan Preet
Ranjan Preet is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Cancer Research and Toxicology, having authored 29 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (6 papers), RNA Research and Splicing (5 papers), RNA modifications and cancer (5 papers), Synthesis and biological activity (4 papers), DNA Repair Mechanisms (3 papers), Extracellular vesicles in disease (3 papers), Bioactive Compounds and Antitumor Agents (3 papers) and Autophagy in Disease and Therapy (3 papers). The work is most often cited by research in Toxicology (85 citations), Cancer Research (215 citations), Organic Chemistry (404 citations), Molecular Biology (839 citations) and Oncology (232 citations). Ranjan Preet has collaborated with scholars based in India, United States and Switzerland. Frequent co-authors include Chanakya Nath Kundu, Purusottam Mohapatra, Tathagata Choudhuri, Shakti Ranjan Satapathy, Dipon Das, Michael D. Wyatt, Dan A. Dixon, Sankar K. Guchhait, Jonathan R. Brody and Prasad V. Bharatam. Their work appears in journals such as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Cancer Research, Bioorganic & Medicinal Chemistry Letters, Oncotarget and Nanomedicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.